Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Kent W. Hunter(National Cancer Institute), Mary Beth Terry(Columbia University Irving Medical Center), Jeffrey N. Weitzel(Cancer Genetics (United States)), Daniel Barrowdale(University of Cambridge), Marco Montagna(Azienda Ospedale - Università Padova), Ignacio Blanco(Hospital Universitari Germans Trias i Pujol), Matthew Kosel, Mark H. Greene(Cancer Institute (WIA)), David E. Goldgar(University of Utah), Daniel Vincent(The Netherlands Cancer Institute), Catherine M. Phelan(University of Southern California), Ed Dicks, Paolo Radice(IFOM), Rita Katharina Schmutzler, Zachary Fredericksen(Karolinska University Hospital), Mads Thomassen(Odense University Hospital), Olga M. Sinilnikova(Hospices Civils de Lyon), François Bacot(The Netherlands Cancer Institute), Xianshu Wang, Curtis Olswold, Andrew K. Godwin, Christian F. Singer, Mia M. Gaudet, kConFab Investigators, Adam Lee, Susan M. Domchek, Penny Soucy, Anna Jakubowska, Andrew Lee, Judy Garber, Susan Peock, Beth Y. Karlan, Frans B. L. Hogervorst, Heli Nevanlinna, Edith Olah, Susan L. Neuhausen, Karoline B. Kuchenbaecker, Irene L. Andrulis, Ana Osorio, Csilla I. Szabo, Marion Piedmonte, Dominique Stoppa-Lyonnet, Trinidad Caldes, Eitan Friedman, Sue Healey, Lesley McGuffog, Fergus J. Couch, Thomas v.O. HANSEN, Joe Dennis, Drakoulis Yannoukakos(National Centre of Scientific Research "Demokritos")
University of Regensburg Publication Server (University of Regensburg)
January 1, 2013
Cited by 0
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
|Nature Genetics|1994|850